Search results for: 'Software License Management Market'

The report explores the transformation of obesity care from generalized BMI-based treatment to AI-enabled precision metabolic management. The study highlights how obesity is increasingly recognized as a heterogeneous, multi-pathway disease influenced by genetic, neurobehavioral, metabolic, and environmental factors, requiring personalized therapeut...

Wound assessment and monitoring systems are devices or digital aids that enable the measurement, imaging, and documentation of wounds by providing 3D assessment of a wound with EMR software integration. With inadequate wound care resulting in various debilitating healthcare-associated infections and adding to the cost burden of patients, modern dig...

The market for endoscope reprocessing systems and workflow solutions in Australia was worth A$61.1 million in 2017. It is expected to grow at a robust CAGR of 10.1% to reach a market size of A$98.7 million in 2022. The market is segmented into two broad segments, which are then divided into several sub-segments as mentioned below – • Endoscope r...

Endoscope reprocessing systems and workflow solutions was a €416.4 million market in the top five Western European countries (UK, Germany, France, Spain, and Italy) in 2017. It is expected to grow at a robust CAGR of 9.5% to reach a revenue of €654.9 million by 2022. The market is segmented into two broad segments which are then divided into severa...

27 Nov 2019  |  North America  |  Market Research

Analysis of the Hospital Asset Management Market, Forecast to 2023

Integration and Interoperability would Drive New Opportunities

Infographics

×

Key Issues Addressed

A critical aspect of efficiency in healthcare organizations is asset management. Hospitals have thousands of assets to track and maintain, and failure of which results in increased waste and downtime, restricted patient flow, decreased quality of care, poor employee productivity, and financial losses. Hospitals are demanding more holistic solution...

Healthcare at home is emerging as one of the fastest-growing fields in modern medicine, driven by the rising demand for outpatient services, home-based monitoring, treatment, and rehabilitation. Increasing patient loads in clinics and hospitals have spurred federal initiatives that encourage the adoption of innovative solutions for decentralized ca...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) encompasses insights across advances in targeted neurological therapies, cancer treatments, and AI-powered drug development. The TOE also features innovators for treatment of metabolic diseases such as obesity and heart failure.The Life Science, Health & Wellnes...

This research study evaluates the evolving global digital therapeutics (DTx) ecosystem, with a focused analysis on Cognitive DTx and Metabolic DTx. The study examines the transition of DTx from emerging digital health tools toward clinically validated, interoperable, and scalable therapeutic platforms integrated within broader healthcare ecosystems...

Cardiovascular diseases (CVDs) remain the leading cause of global morbidity and mortality, with reported cases having doubled since 1990. Today, CVDs account for 1 in 3 deaths worldwide, representing 32% of total global mortality, with heart attacks and ischemic strokes responsible for approximately 85% of these outcomes. The rising burden is stron...